ANI Pharmaceuticals
ANIP
ANIP
116 hedge funds and large institutions have $252M invested in ANI Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 39 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
5% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 39
2.39% less ownership
Funds ownership: 59.05% → 56.66% (-2.4%)
70% less call options, than puts
Call options by funds: $245K | Put options by funds: $806K
Holders
116
Holding in Top 10
1
Calls
$245K
Puts
$806K
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.82M | |
| 3 | +$1.29M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.12M |
| 5 |
ICOM
Investment Counselors of Maryland
Baltimore,
Maryland
|
+$1.11M |
Top Sellers
| 1 | -$3.72M | |
| 2 | -$1.81M | |
| 3 | -$1.68M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.39M |
| 5 |
Two Sigma Investments
New York
|
-$946K |